Can we modify the course of migraine?
Session 4: Current strategies and the future ahead
Piero Barbanti
Associate Professor of Neurology - San Raffaele University, Rome, Italy Director, Headache and Pain Unit - IRCCS San Raffaele
Previous
Switching between anti-CGRP monoclonal antibodies and gepants
Next